Goji berry 枸杞子
Pharmaceutical nameLycii Fructus
The three axes are assessed independently and are never combined into a single score.
KTKP records the origin species as Lycium chinense Mill.. It has not yet been cross-checked against the Korean Pharmacopoeia, so the identification confidence is not raised to an official code mapping. The same drug appears under 5 records as name variants. The same source species also yields 1 other separately registered drug(s) (Lycii Radicis Cortex), which must not be conflated. The name most used for this taxon in current literature is Lycium chinense. The nomenclatural discussion for this herb was flagged for correction during verification; only the verified facts are shown here, with the details in docs/HERB_NAME_RESEARCH.md.
Tradition · what the text describes
탕액편
The sub-section within this volume has not been verified against the original text yet.
The KTKP traditional materia medica record (M0000376) gives the origin species as Lycium chinense Mill., the part used as 열매, and the properties as 감(甘), 무독(無毒), 평(平). It lists 간(肝), 신(腎), 폐(肺) as the channels entered. The same record cites the Donguibogam (1613) as the source for its indications.
Properties & channel entry: 감(甘), 무독(無毒), 평(平) · 간(肝), 신(腎), 폐(肺)
Source species: Lycium chinense Mill. (열매)
Modern · documented evidence
Sciaticaevidence for this indication
- 3 registered trial(s) exist but no published systematic review or RCT was found. Check whether the research is ongoing or simply unpublished.
- The indication was derived automatically from the Condition field of 3 registered trial(s). It reflects what is currently being studied, not a traditional use, and a curator should confirm the label is apt.
Literature
SR 0 · RCT 0 · preclinical 0
No human studies were found within the sources searched. This means "not yet studied", not "does not work".
Query used
We publish the exact query behind these counts so you can reproduce them yourself.
SRC:MED AND ((TITLE_ABS:"Lycium chinense")) AND TITLE_ABS:"Sciatica"Clinical trials
- NCT03879447 — ACTIVE_NOT_RECRUITING
- NCT03571503 — COMPLETED
- NCT03750591 — COMPLETED
Intervertebral Disc Displacementevidence for this indication
- 3 registered trial(s) exist but no published systematic review or RCT was found. Check whether the research is ongoing or simply unpublished.
- The indication was derived automatically from the Condition field of 3 registered trial(s). It reflects what is currently being studied, not a traditional use, and a curator should confirm the label is apt.
Literature
SR 0 · RCT 0 · preclinical 0
No human studies were found within the sources searched. This means "not yet studied", not "does not work".
Query used
We publish the exact query behind these counts so you can reproduce them yourself.
SRC:MED AND ((TITLE_ABS:"Lycium chinense")) AND TITLE_ABS:"Intervertebral Disc Displacement"Clinical trials
- NCT03571503 — COMPLETED
- NCT03959098 — ACTIVE_NOT_RECRUITING
- NCT03750591 — COMPLETED
Lumbar Spinal Stenosisevidence for this indication
- 2 registered trial(s) exist but no published systematic review or RCT was found. Check whether the research is ongoing or simply unpublished.
- The indication was derived automatically from the Condition field of 2 registered trial(s). It reflects what is currently being studied, not a traditional use, and a curator should confirm the label is apt.
Literature
SR 0 · RCT 0 · preclinical 0
No human studies were found within the sources searched. This means "not yet studied", not "does not work".
Query used
We publish the exact query behind these counts so you can reproduce them yourself.
SRC:MED AND ((TITLE_ABS:"Lycium chinense")) AND TITLE_ABS:"Lumbar Spinal Stenosis"Clinical trials
- NCT03879447 — ACTIVE_NOT_RECRUITING
- NCT02975011 — TERMINATED
Safety
auto-proposed · unreviewed
- 6 adverse-event or toxicity record(s) were found. This only flags that literature exists — read the abstracts to decide between "caution" and "harm confirmed".
- The KTKP record states the following traditional contraindication: 외사실열(外邪實熱)이 있는 자(者)나 비록 자니성(滋膩性)은 적다고 하나 비허습체(脾虛濕滯) 또는 장활(腸滑)의 경우는 모두 기(忌)한다.
Adverse-event and toxicity literature
This is not a finding of harm — it lists literature that is retrievable. Read the papers to decide.
- Pharmacological properties, safety, pharmacokinetic and clinical trials of kukoamine A and B. (2026 · Review; Journal Article)
- Lycium chinense Miller fruit extract lowers liver enzyme levels in subjects with mild hepatic dysfunction: a randomized, double-blind, placebo-controlled clinical trial. (2023 · Randomized Controlled Trial; Journal Article)
- Hepatoprotective effects of Lycium chinense Miller fruit and its constituent betaine in CCl4-induced hepatic damage in rats. (2014 · Research Support, Non-U.S. Gov't; Journal Article)
- Cytoprotective effect of the fruits of Lycium chinense Miller against oxidative stress-induced hepatotoxicity. (2010 · Research Support, Non-U.S. Gov't; Journal Article)
- Protective effect of Lycium chinense fruit on carbon tetrachloride-induced hepatotoxicity. (2005 · Comparative Study; Research Support, Non-U.S. Gov't; Journal Article)
Sources
- KTKP materia medica (15002148) (fetched 2026-08-27)
- Europe PMC REST (fetched 2026-08-28)
- ClinicalTrials.gov API v2 (fetched 2026-08-28)
- Europe PMC REST (fetched 2026-08-28)
- ClinicalTrials.gov API v2 (fetched 2026-08-28)
- Europe PMC REST (fetched 2026-08-28)
- ClinicalTrials.gov API v2 (fetched 2026-08-28)
- KTKP materia medica (15002148) (fetched 2026-08-27)
- Europe PMC REST (fetched 2026-08-28)